Metallium (ASX: MTM) Lands First U.S. Defense Deal — Could This Be the Start of Something Big?
Charlie Youlden, September 2, 2025
Metallium Breaks Into U.S. Defense Funding: A Small Contract with Big Implications
Metallium (ASX: MTM) just landed its first U.S. Department of Defense contract, and while the value is only USD 100,000, the implications are far more significant. This Phase 1 Small Business Innovation Research award marks the company’s formal entry into the U.S. federal funding system, a pathway that has historically turned early-stage pilots into multi-million-dollar deals. For a company like Metallium, this is less about the size of the cheque and more about the door it opens.
At the heart of this contract is MTM’s patented Flash Joule Heating process, designed to recover gallium, a critical metal used in high-performance electronics and advanced military technology. Gallium may not be a household name, but it is essential to semiconductors and defence systems, making it a material of growing strategic importance.
For investors, the question now is whether Metallium can turn this initial foothold into something much larger. The Phase 1 trial is just the beginning, but the real story lies in what success here could unlock next.
What are the Best Critical Minerals ASX Stocks to invest in right now?
Check our buy/sell tips
Breaking China’s Grip: Metallium Advances U.S. Gallium Supply Security
MTM’s growth initiatives are closely aligned with U.S. strategic objectives to localise the supply of critical materials such as gallium. At present, the majority of gallium supply and recovery is concentrated in China, creating significant geopolitical risks. Metallium’s technology offers a potential domestic pathway for recovery, directly supporting U.S. national security priorities. The Phase I contract also validates the company’s decision to expand into the U.S. through its Texas subsidiary and could accelerate commercial deployment at its Chambers County site.
Metallium’s Phase I Success Could Unlock Multi-Million-Dollar U.S. Contracts
If Phase I is completed successfully, MTM will be well-positioned to progress to Phase II with larger contracts, supporting the transition from laboratory trials to pilot-scale and eventually full commercial operations. This pathway could see the company move from a pre-revenue stage to becoming a U.S.-based revenue-generating operation, underpinned by strong policy support for critical minerals. The involvement of Rice University further enhances the technical credibility of the program and strengthens Metallium’s position within the U.S. innovation ecosystem.
That said, investors should recognise that the company must demonstrate meaningful results during the six-month program. The ability of its patented technology to deliver reliable and scalable gallium recovery will be a critical factor in determining whether Metallium can progress to the next stage. Failure to achieve these milestones could delay or limit advancement into larger contracts and commercialisation.
Pitt Street Research directors own shares in MTM.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Colgate (NYSE:CL): There’s more to it than toothpaste – it could be the best way to profit from the growth in pet products!
In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there’s a lot more to this 217-year old…
Here are 5 ASX resources stocks with New Zealand projects
In this article, we’re taking a look at ASX resources stocks with New Zealand projects. It is easy for investors…
Ramelius Resources (ASX:RMS) Drops 6% on Q1 Results: Buy the Dip or Warning Sign?
Ramelius Resources (ASX:RMS) shares tumbled 5.86% to $3.30 this morning after the mid-tier gold producer released September quarter results revealing…
